Opinion
Video
Novel Systemic and Topical Treatment for Plaque Psoriasis
In this episode of MEDcast, expert dermatologists discuss exciting advancements in systemic therapies such as JAK inhibitors, and the latest breakthroughs in topical treatments for plaque psoriasis
1:06 Therapeutic innovations in psoriasis
6:55 Challenges with individualizing treatment
7:51 Selective mechanism of deucravacitinib (TYK2 inhibitor)
11:25 Clinical outcomes of deucravacitinib in psoriasis
15:38 Positioning deucravacitinib in the treatment algorithm
17:58 Deucravacitinib vs apremilast
21:41 Novel non-steroidal topicals- tapinarof and roflumilast
26:06 Efficacy and safety of novel topicals
32:13 Benefits of topicals with cross indications
33:55 Remittive effect of tapinarof
37:08 Summary of novel treatments in psoriasis
39:45 Personalizing psoriasis treatment
